Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors
Open Access
- 1 April 2020
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 68 (4), 345-362
- https://doi.org/10.1248/cpb.c19-00895
Abstract
Respiratory syncytial virus (RSV) is one of the most common causes of lower respiratory tract infections and a significant pathogen for both adults and children. Although two drugs have been approved for the treatment of RSV infections, the low therapeutic index of these drugs have led pharmaceutical companies to develop safe and effective small-molecule anti-RSV drugs. The pyrazolo[1,5-a]pyrimidine series of compounds containing a piperidine ring at the 2-position of the pyrazolo[1,5-a]pyrimidine scaffold are known as candidate RSV fusion (F) protein inhibitor drugs, such as presatovir and P3. The piperidine ring has been revealed to facilitate the formation of an appropriate dihedral angle between the pyrazolo[1,5-a]pyrimidine scaffold and the plane of the amide bond for exertion of anti-RSV activity. A molecular-dynamic study on newly designed compounds with an acyclic chain instead of the piperidine ring proposed and demonstrated a new series of pyrazolo[1,5-a]pyrimidine derivatives, such as 9c with a 1-methyaminopropyl moiety, showing similar dihedral angle distributions to those in presatovir. Compound 9c exhibited potent anti-RSV activity with an EC50 value of below 1 nM, which was similar to that of presatovir. A subsequent optimization study on the benzene ring of 9c led to the potent RSV F protein inhibitor 14f with an EC50 value of 0.15 nM. The possibility of improving the biological properties of anti-RSV agents by modification at the 7-position of pyrazolo[1,5-a]pyrimidine is also discussed.Keywords
This publication has 47 references indexed in Scilit:
- Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of lifeThorax, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- A RANDOMIZED, DOUBLE-BLIND STUDY EXAMINING THE COMPARATIVE EFFICACIES AND SAFETY OF INHALED EPINEPHRINE AND NASAL DECONGESTANT IN HOSPITALIZED INFANTS WITH ACUTE BRONCHIOLITISThe Pediatric Infectious Disease Journal, 2010
- Mechanisms of action of ribavirin against distinct virusesReviews in Medical Virology, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Effective Born radii in the generalized Born approximation: The importance of being perfectJournal of Computational Chemistry, 2002
- Replica-exchange molecular dynamics method for protein foldingChemical Physics Letters, 1999
- High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infectionThe Journal of Pediatrics, 1994
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionThe New England Journal of Medicine, 1986
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME NUCLEOSIDES RESEMBLING GUANOSINE: IMIDAZO[1, 2‐a] PYRIMIDINE NUCLEOSIDESAnnals of the New York Academy of Sciences, 1975